The gold standard for eye care would be preventative medicine, allowing no need to ever again operate on the eye, says Mark Blumenkranz, MD. In this video, learn how experts hope this can someday be accomplished with lasers and biopharmaceuticals.
Read Transcript
Well, I think lasers and biopharmaceuticals, and what we'd like to do is eventually avoid the need to ever have to operate on anyone, and for anyone to even develop the disease. That's the goal standard, is to essentially to engage in preventive medicine and some drugs will get us there.
Mark S. Blumenkranz, MD, is the H.J. Smead Professor and Chairman of the Department of Ophthalmology at Stanford University. Dr. Blumenkranz’s primary clinical interests center on medical and surgical treatment of vitreoretinal diseases.
